Glucagon for Beta Blocker Overdose: Product Use Overview
Published: July 26, 2026 17:52
Author: Mark Lemoine
Glucagon, a 29-amino-acid peptide hormone (recombinant vs. synthetic formulations), is indicated for beta-blocker overdose via positive inotropic effects. This overview examines purity (>99%), market growth (emergency peptides CAGR 6.8%), brand comparisons (Novo Nordisk’s GlucaGen vs. Fresenius Kabi generics), technology pros (fast onset) and cons (nausea, stability), cold-chain logistics, and GMP certifications. Citing >150 case reports and selection guides (purity certs, factory audits), it reinforces EEAT for pharmaceutical-grade sourcing.